Peroxidation of lipoproteins in multiple sclerosis

Journal of the Neurological Sciences

Volumn 311, Issue 1-2, 2011, Pages 92-97

  Ferretti, Gianna ^a   Bacchetti, Tiziana ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Antioxidant; High density lipoproteins; Lipid peroxidation; Low density lipoproteins; Multiple sclerosis; Oxidative damage; Paraoxonase; Reactive oxygen species

Indexed keywords

ANTIOXIDANT; APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; APOLIPOPROTEIN A4; APOLIPOPROTEIN B100; APOLIPOPROTEIN B48; APOLIPOPROTEIN C; APOLIPOPROTEIN D; APOLIPOPROTEIN E; ARYLDIALKYLPHOSPHATASE 1; CATALASE; CHOLESTEROL ESTER; CLUSTERIN; FREE RADICAL; GLUTATHIONE PEROXIDASE; HIGH DENSITY LIPOPROTEIN; HYDROPEROXIDE DERIVATIVE; LIPID HYDROPEROXIDE; LOW DENSITY LIPOPROTEIN; MYELIN; OXIDIZED LOW DENSITY LIPOPROTEIN; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

AUTOIMMUNITY; AXONAL INJURY; BRAIN; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; DEMYELINATION; ENZYME ACTIVITY; HUMAN; IN VIVO STUDY; INFLAMMATION; LIPID PEROXIDATION; MULTIPLE SCLEROSIS; NEUROTOXICITY; OXIDATIVE STRESS; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVIEW;

EID: 81255149429     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2011.09.004     Document Type: Article

References (68)

1. H.N. Ginsberg Lipoprotein physiology Endocrinol Metab Clin North Am 27 1998 503 519 (Pubitemid 28446945)
2. I. Dobreva, G. Waeber, and C. Widmann Lipoproteins and mitogen-activated protein kinase signaling: a role in atherogenesis? Curr Opin Lipidol 17 2006 110 121
3. Borghini, F. Barja, D. Pometta, and R.W. James Characterization of subpopulations of lipoprotein particles isolated from human cerebrospinal fluid Biochim Biophys Acta 1255 1995 192 200
4. M.J. Ladu, C. Reardon, L. Van Eldik, A.M. Fagan, G. Bu, and D. Holtzman Lipoproteins in the central nervous system Ann N Y Acad Sci 903 2000 167 175 (Pubitemid 30251555)
5. S. Koch, N. Donarski, K. Goetze, M. Kreckel, H.J. Stuerenburg, and C. Buhmann Characterization of four lipoprotein classes in human cerebrospinal fluid J Lipid Res 42 2001 1143 1151 (Pubitemid 32645797)
6. H. Hayashi Lipid metabolism and glial lipoproteins in the central nervous system Biol Pharm Bull 2011 453 461
7. I. Levitan, S. Volkov, P.V. Subbaiah, and L.D.L. Oxidized Diversity, patterns of recognition, and pathophysiology Antioxid Redox Signal 13 2010 39 75
8. H. Itabe Oxidative modification of LDL: its pathological role in atherosclerosis Clin Rev Allergy Immunol 37 2009 4 11
9. G. Ferretti, T. Bacchetti, A. Nègre-Salvayre, R. Salvayre, N. Dousset, and G. Curatola Structural modifications of HDL and functional consequences Atherosclerosis 184 2006 1 7 (Pubitemid 41721062)
10. C.N. Bassett, K.S. Montine, M.D. Neely, L.L. Swift, and T.J. Montine Cerebrospinal fluid lipoproteins in Alzheimer's disease Microsc Res Tech 50 2000 282 286 (Pubitemid 30651167)
11. S. Arlt, B. Finckh, U. Beisiegel, and A. Kontush Time-course of oxidation of lipids in human cerebrospinal fluid in vitro Free Radic Res 32 2000 103 114 (Pubitemid 30056787)
12. K. Sato, E. Malchinkhuu, Y. Horiuchi, C. Mogi, H. Tomura, and M. Tosaka HDL-like lipoproteins in cerebrospinal fluid affect neural cell activity through lipoprotein-associated sphingosine 1-phosphate Biochem Biophys Res Commun 359 2007 649 654 (Pubitemid 46899000)
13. Z. Balazs, U. Panzenboeck, A. Hammer, A. Sovic, O. Quehenberge, and E. Malle Uptake and transport of high-density lipoprotein (HDL) and HDL-associated alpha-tocopherol by an in vitro blood/brain barrier model J Neurochem 89 2004 939 950 (Pubitemid 38684741)
14. B. Dehouck, L. Fenart, M.P. Dehouck, A. Pierce, G. Torpier, and R. Cecchelli A new function for the LDL receptor: transcytosis of LDL across the blood-brain barrier J Cell Biol 138 1997 877 889 (Pubitemid 27365049)
15. J.K. Boyles, C.D. Zoellner, L.J. Anderson, L.M. Kosik, R.E. Pitas, and K.H. Weisgraber A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve J Clin Invest 83 1989 1015 1031 (Pubitemid 19080637)
16. T. Nakano, and A. Nagata Immunochemical detection of circulating oxidized high-density lipoprotein with antioxidized apolipoprotein A-I monoclonal antibody J Lab Clin Med 141 2003 378 384 (Pubitemid 36737150)
17. Stocker R, Keaney Jr JF. Role of oxidative modifications in atherosclerosis. Physiol Rev 2004;84:1381-1478. (Pubitemid 39302636)
18. G.M. Chisolm, S.L. Hazen, P.L. Fox, and M.K. Cathcart The oxidation of lipoproteins by monocytes-macrophages J Biol Chem 274 1999 25959 25962
19. V.M. Darley-Usmar, N. Hogg, V.J. O'Leary, M.T. Wilson, and S. Moncada The simultaneous generation of superoxide and nitric oxide can initiate lipid peroxidation in human low density lipoprotein Free Radic Res Commun 17 1992 9 20
20. J. Heinecke, H. Rosen, and A. Chait Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture J Clin Invest 74 1984 1890 1894 (Pubitemid 15214102)
21. E. Niki Lipid peroxidation: physiological levels and dual biological effects Free Radic Biol Med 47 2009 469 484
22. N. Mattsson, S. Haghighi, O. Andersen, Y. Yaoc, L. Rosengrenb, and K. Blennowa Elevated cerebrospinal fluid F2- isoprostane levels indicating oxidative stress in healthy siblings of multiple sclerosis patients Neurosci Lett 13 2007 233 236
23. V. Leoni, and C. Caccia Oxysterols as biomarkers in neurodegenerative diseases Chem Phys Lipids 164 2011 515 524
24. N. Leitinger Cholesteryl ester oxidation products in atherosclerosis Mol Aspects Med 24 2003 239 250 (Pubitemid 36945024)
25. V.W. Bowry, K.K. Stanley, and R. Stocker HDL is the major carrier of lipid hydroperoxides in human blood plasma from fasting donors Proc Natl Acad Sci USA 89 1992 10316 10320
26. E.A. Podrez Anti-oxidant properties of high-density lipoprotein and atherosclerosis Clin Exp Pharmacol Physiol 37 2010 719 725
27. J.R. Nofer, B. Kehrel, M. Fobker, B. Levkau, G. Assmann, and A. von Eckardstein HDL and arteriosclerosis: beyond reversecholesterol transport Atherosclerosis 161 2002 1 16 (Pubitemid 34214816)
28. A. Negre-Salvayre, N. Dousset, G. Ferretti, T. Bacchetti, G. Curatola, and R. Salvayre Antioxidant and cytoprotective properties of high-density lipoproteins in vascular cells Free Radic Biol Med 41 2006 1031 1040 (Pubitemid 44348872)
29. A.D. Watson, J.A. Berliner, S.Y. Hama, B.N. La Du, K.F. Faull, and A.M. Fogelman Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein J Clin Invest 96 1995 2882 2891
30. M. Rosenblat, L. Gaidukov, O. Khersonsky, J. Vaya, R. Oren, and D.S. Tawfik The catalytic histidine dyad of high density lipoprotein-associated serum paraoxonase-1 (PON1) is essential for PON1-mediated inhibition of low density lipoprotein oxidation and stimulation of macrophage cholesterol efflux J Biol Chem 281 11 2006 7657 7665 (Pubitemid 43847536)
31. G. Ferretti, T. Bacchetti, S. Masciangelo, and V. Bicchiega HDL-paraoxonase and membrane lipid peroxidation: a comparison between healthy and obese subjects Obesity 18 2010 1079 1084
32. Y. Soto, H. Conde, R. Aroche, V. Brito, P. Luaces, and A. Nasiff Autoantibodies to oxidized low density lipoprotein in relation with coronary artery disease Hum Antibodies 18 2009 109 117
33. M. Navab, G.M. Ananthramaiah, S.T. Reddy, B.J. Van Lenten, B.J. Ansell, and S. Hama The double jeopardy of HDL Ann Med 37 2005 173 178 (Pubitemid 40780434)
34. L. Jaouad, C. Milochevitch, and A. Khalil PON1 paraoxonase activity is reduced during HDL oxidation and is an indicator of HDL antioxidant capacity Free Radic Res 37 2003 77 83 (Pubitemid 36124333)
35. J. van Horssen, M.E. Witte, G. Schreibelt, and H.E. de Vries Radical changes in multiple sclerosis pathogenesis Biochim Biophys Acta 1812 2011 141 150
36. R.E. Gonsette Neurodegeneration in multiple sclerosis: the role of oxidative stress and excitotoxicity J Neurol Sci 274 2008 48 53
37. Y. Gilgun-Sherki, E. Melamed, and D. Offen The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy J Neurol 251 2004 261
38. J. Newcombe, H. Li, and M.L. Cuzner Low density lipoprotein uptake by macrophages in multiple sclerosis plaques: implications for pathogenesis Neuropathol Appl Neurobiol 20 1994 152 162 (Pubitemid 24123546)
39. O.A. Bizzozero, G. DeJesus, K. Callahan, and A. Pastuszyn Elevated protein carbonylation in the brain white matter and gray matter of patients with multiple sclerosis J Neurosci Res 81 2005 687 695 (Pubitemid 41532164)
40. O.A. Bizzozero, G. DeJesus, H.A. Bixler, and A. Pastuszyn Evidence of nitrosative damage in the brain white matter of patients with multiple sclerosis Neurochem Res 30 2005 139 149 (Pubitemid 40254214)
41. L. Haider, M.T. Fischer, J.M. Frischer, J. Bauer, R. Höftberger, and G. Botond Oxidative damage in multiple sclerosis lesions Brain 134 2011 1914 1924
42. E. Miller, M. Mrowicka, J. Saluk-Juszczak, and M. Ireneusz The level of isoprostanes as a non-invasive marker for in vivo lipid peroxidation in secondary progressive multiple sclerosis Neurochem Res 36 2011 1012 1016
43. G. Ferretti, T. Bacchetti, F. Principi, F. Di Ludovico, B. Viti, and V.A. Angeleri Increased levels of lipid hydroperoxides in plasma of patients with multiple sclerosis: a relationship with paraoxonase activity Mult Scler 11 2005 677 682 (Pubitemid 41685138)
44. M. Koch, J. Mostert, A.V. Arutjunyan, M. Stepanov, A. Teelken, and D. Heersema Plasma lipid peroxidation and progression of disability in multiple sclerosis Eur J Neurol 14 2007 529 533 (Pubitemid 46587841)
45. M.S. Keles, S. Taysi, N. Sen, H. Aksoy, and F. Akçay Effect of corticosteroid therapy on serum and CSF malondialdehyde and antioxidant proteins in multiple sclerosis Can J Neurol Sci 28 2001 141 143 (Pubitemid 32521803)
46. H.T. Besler, and S. Comoǧlu Lipoprotein oxidation, plasma total antioxidant capacity and homocysteine level in patients with multiple sclerosis Nutr Neurosci 6 2003 189 196 (Pubitemid 36656698)
47. Z. Sternberg, C. Hennies, D. Sternberg, P. Wang, P. Kinkel, and D. Hojnacki Diagnostic potential of plasma carboxymethyllysine and carboxyethyllysine in multiple sclerosis J Neuroinflammation 7 2010 72
48. S. Yamagishi, and T. Matsui Advanced glycation end products (AGEs), oxidative stress and diabetic retinopathy Curr Pharm Biotechnol 12 2011 362 368
49. G. Ferretti, T. Bacchetti, F. DiLudovico, B. Viti, V.A. Angeleri, and M. Danni Intracellular oxidative activity and respiratory burst of leukocytes isolated from multiple sclerosis patients Neurochem Int 48 2006 87 92 (Pubitemid 41832442)
50. N. Mossberg, C. Movitz, K. Hellstrand, T. Bergström, S. Nilsson, and O. Andersen Oxygen radical production in leukocytes and disease severity in multiple sclerosis Neuroimmunol 213 2000 131 134
51. K. Rezai-Zadeh, D. Gate, and T. Town CNS infiltration of peripheral immune cells: d-day for neurodegenerative disease? J Neuroimmune Pharmacol 4 2009 462 475
52. E. Gray, T.L. Thomas, S. Betmouni, N. Scolding, and S. Love Elevated activity and microglial expression of myeloperoxidase in demyelinated cerebral cortex in multiple sclerosis Brain Pathol 18 2008 86
53. S.C. Bondy, and C.P. LeBel The relationship between excitotoxicity and oxidative stress in the central nervous system Free Radic Biol Med 14 1993 633 642 (Pubitemid 23172570)
54. C. Griot, M. Vandevelde, A. Richard, E. Peterhans, and R. Stocker Selective degeneration of oligodendrocytes mediated by reactive oxygen species Free Radic Res Commun 11 1990 181 193
55. S.K. Thorburne, and B.H.J. Juurlink Low glutathione and high iron govern the susceptibility of oligodendroglial precursors to oxidative stress J Neurochem 67 1996 1014 1022 (Pubitemid 26277913)
56. M. Aviram Interaction of oxidized low density lipoprotein with macrophages in atherosclerosis, and the antiatherogenicity of antioxidants Eur J Clin Chem Clin Biochem 34 1996 599 608 (Pubitemid 26293746)
57. I.Y. Choi, S.P. Lee, D.R. Denney, and S.G. Lynch Lower levels of glutathione in the brains of secondary progressive multiple sclerosis patients measured by 1H magnetic resonance chemical shift imaging at 3 T Mult Scler 17 2011 289 296
58. G.E. Jensen, G. Gissel-Nielsen, and J. Clausen Leukocyte glutathione peroxidase activity and selenium level in multiple sclerosis J Neurol Sci 48 1980 61 67 (Pubitemid 10009754)
59. H.T. Besler, S. Comoglu, and Z. Okcu Serum levels of antioxidant vitamins and lipid peroxidation in multiple sclerosis Nutr Neurosci 5 2002 215 220 (Pubitemid 34568217)
60. E. Karg, P. Klivenyi, I. Nemeth, K. Bencsik, S. Pinter, and L. Vecsei Non enzymatic antioxidants of blood in multiple sclerosis J Neurol 246 1999 533
61. V. Calabrese, R. Raffaele, E. Cosentino, and V. Rizza Changes in cerebrospinal fluid levels of malondialdehyde and glutathione reductase activity in multiple sclerosis Int J Clin Pharmacol Res 14 1994 119
62. L. Jofre-Monseny, A.M. Minihane, and G. Rimbach Impact of apoE genotype on oxidative stress, inflammation and disease risk Mol Nutr Food Res 52 2008 131 145 (Pubitemid 351211806)
63. B. Zhang, S. Pu, B. Li, J. Ying, X.W. Song, and C. Gao Comparison of serum apolipoprotein A-I between Chinese multiple sclerosis and other related autoimmune disease Lipids Health Dis 9 2010 34
64. N. De Stefano, M.L. Bartolozzi, B. Nacmias, V. Zipoli, M. Mortilla, and L. Guidi Influence of apolipoprotein E epsilon4 genotype on brain tissue integrity in relapsing-remitting multiple sclerosis Arch Neurol 61 2004 536 540 (Pubitemid 38923743)
65. M.I. Sedano, P. Calmarza, L. Perez, and J.M. Trejo No association of apolipoprotein E epsilon4 genotype with faster progression or less recovery of relapses in a Spanish cohort of multiple sclerosis Mult Scler 12 2006 13 18 (Pubitemid 43169233)
66. A. van der Walt, J. Stankovich, M. Bahlo, B.V. Taylor, I.A. van der Mei, and S.J. Foote Apolipoprotein genotype does not influence MS severity, cognition, or brain atrophy Neurology 73 2009 1018 1025
67. S.C. Kivatinitz, M.A. Pelsman, A.C. Alonso, L. Bagatolli, and S. Quiroga High-density lipoprotein aggregated by oxidation induces degeneration of neuronal cells J Neurochem 69 1997 2102 2114 (Pubitemid 27452758)
68. J.N. Keller, K.B. Hanni, S.P. Gabbita, V. Friebe, M.P. Mattson, and M.S. Kindy Oxidised lipoproteins increase reactive oxygen species formation in microglia and astrocyte cell lines Brain Res 830 1999 10 15 (Pubitemid 29251707)